The development of safe and effective antiviral agents has been a slow process, largely because of the difficulty in distinguishing between virus and host functions; materials toxic to the virus are frequently harmful also to the host in which the agent resides. Recently, techniques which target nucleic acid sequences as a means of reducing gene Here we show that AUC, CUC, and AUU are alternative sites which can be cleaved by trans-acting ribozymes. This finding is important given the aforementioned restriction of available sites, imposed by secondary structure.
directed toward lymphocytic choriomeningitis virus (LCMV), the prototype of the arenavirus family. Using ribozymes of the hammerhead variety, we have identified several sites on the LCMV genome which can be efficiently cleaved in trans. The efficiency of cleavage is site dependent, and we demonstrate that secondary structure at the target site can abolish ribozyme cleavage. Computer-assisted analysis indicates that much of the LCMV genome may be involved in base pairing, which may render it similarly resistant to ribozyme attack.
The few remaining open regions of LCMV lack a GUC target site, on which most studies to date have relied.
Here we show that AUC, CUC, and AUU are alternative sites which can be cleaved by trans-acting ribozymes. This finding is important given the aforementioned restriction of available sites, imposed by secondary structure.
A major obstacle to the development of successful antiviral therapies has been and remains the problem of specificity: most materials wnich interrupt the virus life cycle are detrimental also to the host in which these obligate intracellular agents reside. Much effort has been invested in identifying those facets of the virus which distinguish it from its host. Thus, for example, virus-encoded polymerases (or other virus-specific functions) have been analyzed, and inhibitors have been sought. However, one distinguishing feature between host and virus is the nucleic acid sequence itself. Thus, an activity which could functionally inhibit or destroy nucleic acid molecules in a sequence-specific manner would be worthy of evaluation as a potential antiviral therapy, in which virus RNAs could be specifically de- stroyed without harming host cell molecules. The discovery of ribozymes (5) , RNA molecules which catalyze RNA cleavage in a sequence-specific manner, has provided one such activity.
There are several types of ribozyme, classified by primary (and proposed secondary) structure; to date, the best-characterized type of ribozyme is the hammerhead, found in vivo in plant viroids and virusoids and in transcripts of newt satellite DNA (3, 9, 10, 21) . In nature, these enzymes cleave intramolecularly (i.e., in cis) and cut 3' to the sequence GUC. They are, however, open to manipulation on both points; they can be made to cut intermolecularly (i.e., in trans), and the cleavage site can be NUX (where N is any base and X is A, C, or U [16, 23] ). Cleavage requires divalent cations, usually Mg2", and yields 5'-hydroxyl and 2',3'-phosphodiester termini (15) . Hammerhead ribozymes con-* Corresponding author. tain two separable functions: a catalytic core region containing several conserved bases, which cleaves the target RNA, and flanking regions which, by nucleic acid complementarity, direct the ribozyme core to a specific target site. Thus, by attaching the core to sequences complementary to those flanking the selected target site GUC, ribozymes could be designed to specifically cleave almost any target RNA molecule (14, 30) .
Ribozymes have been shown to exert some effect on one animal virus, the human retrovirus human immunodeficiency virus type 1, in cell culture (27) (18) ; LCMV, the prototype of the family, has a bisegmented single-stranded RNA genome. The short (S) segment encodes two proteins, glycoprotein C (GP-C), a 498-amino-acid precursor which undergoes posttranslational cleavage to yield the two mature virus polypeptides GP-1 and GP-2 (2), and a 558-residue nucleoprotein (NP); the long (L) segment also encodes two proteins, the large L protein, the putative viral polymerase (24) , and the Z protein, a zinc-containing protein of undefined function (26) . The S segment is ambisense (1) ; it encodes GP-C in the positive sense and NP in the negative sense. The two convergently transcribed genes are separated by a short intergenic region, which contains a potential hairpin stemloop structure. Figure 1 tion of the proposed replication strategy of arenaviruses, the location of the proposed hairpin structure (present both in the genome S segment and in its antigenomic counterpart, S'), and the sequence of the proposed stem-loop structure.
The complete sequence of the LCMV short segment is known (25) , and full-length cDNA clones are available. We have identified potential ribozyme cleavage sites in LCMV and have designed appropriate ribozymes. Here we show that (i) ribozymes which cleave at various points along the arenavirus genome, antigenome, and mRNA can be designed, (ii) the ribozymes work very efficiently in cis, and some work also in trans, (iii) the cis activity is similar both in Mg2+ and Mn2+, (iv) the cis-acting ribozymes are highly active, even at low temperatures, (v) Ribozyme reactions using purified RNAs. RNA, gel purified as described above, was dissolved in 50 mM Tris-HCl [pH 7 .5]; where necessary, relative quantities were estimated by measurement of radioactivity (corrected for the length of the molecule). The RNAs were denatured (1 min, 95°C) and then cooled on ice. MgCl2 was added to a final concentration of 10 mM, and the reactions were carried out at the temperatures and times described in the figure legends. Analytical electrophoresis was carried out as described above.
Computer-assisted prediction of RNA secondary structure. Prediction of secondary structure was carried out by using the RNAFOLD program of PCGene (IntelliGenetics, Mountain View, Calif.) on an IBM-compatible computer.
Growth of LCMV, RNA extraction, and Northern (RNA) blotting. NIH 3T3 cells (ATCC CRL 1658) were infected (multiplicity of infection of 1) with LCMV (strain Arm 53b), and 48 h later, cytoplasmic RNA was harvested by standard methods. For Northern blotting, RNA was resuspended in 50% formamide-10% formaldehyde-0.5 x morpholinepropanesulfonic acid (MOPS), heated at 65°C for 3 min, and electrophoresed on a 1.5% agarose-6% formaldehyde-lx MOPS gel. Following capillary transfer to nitrocellulose and baking, the blot was probed with a probe made by random hexamer priming, specific for LCMV NP.
RESULTS
Selection of a target site within the arenavirus hairpin and plasmid construction. Initially, the complete sequence of the LCMV S segment (both S and S' strands) was scanned for (A) Plasmid constructions of Ribi and target RNAs. As described in the text, a TaqI-HindIII fragment from the LCMV S segment (containing only the descending arm of the hairpin) was cloned into pBKS (pBluescript KS; Stratagene), to yield pBKS-a. Next, oligodeoxynucleotides encoding Ribl were cloned into pBKS, giving pBKS-Ribl, or into pBKS-at (between the T7 promoter and the target sequence) to yield pBKS-Ribl-at. Following restriction enzyme cleavage to linearize the template DNA, in vitro transcription using 17 RNA polymerase may be carred out, generating a single RNA molecule in each case; the RNA molecule contains either the target RNA alone (from pBKS-a), the ribozyme alone (from pBKS-Ribl), or the two attached, with the ribozyme upstream of the target site (i.e., in cis; firom pBKS-Ribl-c). (B) Proposed secondary hammerhead structure of the nbozyme formed by transcrption of pBKS-Ribl-a.
GUX ribozyme cleavage sites; 275 were identified, of which 103 were GUC. One site was chosen because of its unusual properties; the GUC at positions 1618 to 1620 lies on the descending arm of the intergenic hairpin stem (Fig. 1B) . Since the structure of the hairpin stem dictates that the same site (with identical flanking sequences) can be found at the equivalent location in the hairpin stem of the S' (antigenomic) strand, a ribozyme directed toward this site would have the unique ability to cleave both S and S' strands and consequently might have enhanced antiviral effects. This advantage, although to some extent countered by our concern that the potential hairpin might interfere with ribozyme function, led us to design a ribozyme (Ribl) with a catalytic core flanked by sequences which would direct the molecule to this cleavage site (Fig. 2) . First, to provide a target molecule lacking the predicted stem-loop structure, we subcloned the target sequence, taking advantage of a TaqI site (TCGA, positions 1602 to 1605; Fig. 1B ) in the loop of the hairpin and a HindIII site distal to it; the descending arm of the stem (which contains the proposed cleavage site) was thus separated from the ascending arm, effectively disrupting the stem structure. The fragment, oriented such that synthesis of the desired RNA would be driven by the T7 RNA polymerase promoter, was cloned into pBKS, resulting in pBKS-a. Next, the ribozyme sequences were made as complementary oligodeoxynucleotides and were cloned both into pBKS, downstream of the T7 RNA polymerase promoter, giving pBKS-Ribl, and into pBKS-a, upstream of the target sequences, giving pBKS-Ribl-a ( Fig. 2A) . The latter plasmid thus encodes both the ribozyme and its target sequence, covalently linked; the proposed secondary structure of this cis-acting hammerhead ribozyme, produced by in vitro transcription using T7 RNA polymerase, is shown ( Fig.   2B ).
Cleavage of a ribozyme target site in the hairpin of the LCMV S segment. We first wished to determine whether Ribl was functional. Following linearization of pBKSRibl-a with HindIII, in vitro transcription using T7 RNA polymerase, gel electrophoresis, and autoradiography (see Materials and Methods), three bands were seen (Fig. 3 , track B). Band sizes were consistent with full-length primary transcript and the two bands which should result from autocatalytic cleavage; presumably the full-length molecules undergo cleavage during or soon after their in vitro synthesis. The control RNA molecule, transcribed from pBKS-a and lacking the cloned ribozyme oligonucleotide, remains min) prior to electrophoresis and autoradiography (track E). The full-length band undergoes cleavage to yield two bands of the predicted size (track E). The exact position of hammerhead ribozyme cleavage has been confirmed by direct sequencing (enzymatic RNA degradation) of 5'-end-labeled, gel-purified cleavage products. Cleavage occurs at the expected location, confirming the observations of other groups.
Kinetics, temperature, and ionic requirements of ribozyme cleavage. Since some ribozymes appear to operate best under nonphysiological conditions, we wished to estimate the optimal temperature and ionic requirements for cleavage. A full-length band identical to that shown in Fig. 3 was excised, gel purified, and added to ice-cold buffer (50 mM Tris-HCl [pH 7.5]). After denaturation and additionof MgCl2 to a final concentration of 10 mM, one aliquot was held on ice, while others were placed at the temperatures indicated in the legend to Fig. 4a ; following a 30-min incubation, samples were subjected to electrophoresis and autoradiography. All samples showed marked cleavage, and a temperature of 25°C or above was sufficient to allow full cleavage (Fig. 4a) . Since even the sample held on ice underwent marked cleavage, subsequent analyses used as a negative control the RNA molecule held in 50 mM Tris-HCl (pH 7.5) (no divalent metal ions). Next, the same ribozyme/target molecule was used to execute a time course experiment in which samples were placed at 37°C, and aliquots were withdrawn onto dry ice at the time points shown (Fig. 4b) . The results show that cleavage is very rapid, being essentially complete within 5 min. Finally, since some ribozymes which show a preference for Mn2+ over Mg2+ have been described (8) , the molecule was incubated (30 min, 37°C) with various concentrations of each divalent cation; Fig. 4c shows that although there may be a slight preference for Mn2+, both ions can be utilized effectively at 10 mM for hammerhead Ribl cleavage in vitro. Therefore, this ribozyme is highly effective under temperature and ionic conditions which should be similar to those found in the intracellular environment. Studies with various concentrations of monovalent cations (Na+ and K+) showed no marked effects (data not shown), in contrast to the effects on some group I ribozymes (20) .
Target site secondary structure: effects on ribozyme cleavage. The foregoing results indicated that the selected ribozyme was fully functional in cis upon a target lacking any predicted extensive secondary structure. However, as explained above, the target site, which was chosen because of its existence in both S and S' strands of LCMV, may normally be part of the stem of an intergenic hairpin loop (Fig. 1B) . The ribozyme was therefore cloned upstream of cDNA containing all of the proposed hairpin (an EcoRIHindIlI fragment, shown in Fig. 1A) , and experiments similar to those described above were carried out. Despite exhaustive attempts at a variety of temperatures (up to 95°C) and in various reaction buffers (including some containing 50% formamide), no cleavage was seen (data not shown). To confirm that secondary structure at the target site was the probable cause of loss of cleavage, the viral S-segment TaqI-TaqI fragment, carrying the ascending arm of the hairpin stem, was cloned in each orientation between the Ribl and target sequences in plasmid pBKS-Ribl-ot (Fig. 5a ). asterisks in Fig. 5a ), more than two product bands would be expected. Only two product bands are seen (Fig. Sb, track C); their sizes indicate that cleavage is occurring at the proximal, rather than the distal, site. Once cleavage has occurred proximally, the distal site will be released on a product molecule and will thus no longer be covalently attached to the ribozyme; subsequent cleavage of the distal site will be in trans, which is less efficient than in cis (see below). In contrast to the cleavage seen above, RNA from pBKSRibl-a,B, in which the hairpin is re-formed, is not cleaved (Fig. Sb, track B) . The most likely explanation of this finding is that first, the secondary structure assumed to exist in this region of arenavirus does indeed form, at least in in vitroderived RNA, and second, this structure is sufficient to prevent ribozyme cleavage of the target site.
Activity in trans of Ribl. Since any antiviral effects of ribozymes will be exerted on viral RNA molecules in trans, we tested Ribl against several target RNA molecules to which it was not covalently linked. Activity was seen against RNA transcribed from the TaqI-HindIII fragment cloned into pBKS-a, i.e., RNA which contains only one arm of the hairpin stem. Activity increased with time ( Fig. 6a) and was dependent on the ratio of ribozyme to target (Fig. 6b) trans activity is thus demonstrable, albeit at reduced levels, against a target RNA which lacks the potential to form the hairpin stem-loop structure. In contrast, no activity was seen against full-length LCMV S RNA in vitro or against the truncated EcoRI-HindIII fragment thereof (which contains the full hairpin stem-loop [ Fig. 1A and data not shown]), again implicating the target RNA secondary structure in inhibition of ribozyme activity.
Improved trans activity against target sites selected for lack of apparent secondary structure. The dramatic effect of the hairpin stem-loop structure in inhibiting both cis and trans activity of Ribl lends weight to the belief that absence of secondary structure should be a primary consideration in choosing a potential target site. Consequently, we used the program RNAFOLD (see Materials and Methods) to screen the LCMV S and S' segments for regions of apparent secondary structure. This program predicts that the great majority of each of these 3,376-base RNA molecules is involved in extensive secondary structure, and thus these regions were excluded from further analysis. The few regions free of predicted structure were scanned for a potential ribozyme cleavage site. No GUC sites were identified, but several NUX motifs were present. The locations of four of these sites, and their sequences, are shown in Fig. 7a (Fig. 7b) shown; Rib3, Rib4, and Rib5 are directed against the S genomic RNA, and Rib6 is directed toward the NP mRNA. (b) Ability of each of these four molecules to cleave target RNA at a 50:1 molar ratio of ribozyme to target in trans. Target RNAs were transcribed from a plasmid containing a cDNA of 652 bases in length (genomic bases 2711 to 3363), flanked by promoters for T3 and T7 RNA polymerases; depending on the polymerase-template combination used, the target RNA was genomic sense (tracks A to D) or mRNA sense particular, Rib3, Rib4, and Rib5 show almost complete cleavage of target RNA species after a 12-h incubation (50 mM TrisHCI-10 mM MgCl2, 37°C; ribozyme/target ratio of approximately 50:1); in contrast, both Ribl (Fig. 6b, track F) and Rib6 (Fig. 7b , track E) cleave much less effectively in trans at the same ribozyme/target molar ratio. The reason for the different efficiencies of cleavage by these five transacting ribozymes is unknown. It is possible that the target sites for Ribl and Rib6 assume some higher-order structure not predicted by the computer analysis. Differences in trans cleavage of different target sites has been previously reported (22) , although the precise reason was not identified. We have found that the extent of cleavage by Rib3, Rib4, and Rib5 shown in Fig. 7b can be achieved at even lower molar ratios (20:1) and with shorter incubation time (4 h; data not shown).
The degree to which the computer program helped in identifying sequences involved in secondary structure is unclear. The program predicts the intergenic hairpin structure, which we show renders a target site resistant to ribozyme attack; it is possible that some or all of the other secondary structural motifs identified by RNAFOLD would have been similarly refractory to cleavage. However, in the absence of experimental data about the secondary structure of LCMV RNAs, it remains entirely possible that some of the predicted secondary structures are in fact absent; conversely, some of the regions that we have chosen may in reality be involved in base pairing.
We also show in Fig. 7 that cleavage occurs at sites other than GUC, thus extending the potential range of these hammerhead ribozymes: the random frequency of GUC is 1/64, that of GUX is 3/64, and that of NUX is 3/16. Therefore, the use of NUX rather than GUC gives a 12-fold increase in the number of potential target sites.
Activity against intact LCMV RNA. The templates in the foregoing experiments are partial copies of LCMV RNA, generated by in vitro transcription. However, if the ribozymes are to be of therapeutic value, they must cleave full-length LCMV RNA molecules. Consequently, RibS was transcribed in vitro as before but in the absence of radioactive tracer. This cold ribozyme was incubated (15 min, 37°C) with LCMV RNA extracted from infected cells. The samples were then subjected to gel electrophoresis and Northern blotting, followed by hybridization with a probe specific for the NP region of LCMV. The resultant autoradiograph (Fig.  8) showed that RibS incubation releases a band of the appropriate size (around 150 bases); when ribozyme alone was present (in the absence of input LCMV RNA), no bands were seen (data not shown).
DISCUSSION
As outlined in the introduction, the development of safe and effective antiviral treatments has foundered on the rocks of specificity; it is relatively easy to identify compounds which interfere with the virus life cycle, but the vast majority of these are toxic also to the host upon which the virus depends. Most approaches to the development of specific antiviral agents have concentrated on inhibition of protein (tracks E and F). Ribozymes were incubated with target RNAs (all molecules gel purified) in a 50:1 molar ratio. To realize the maximum potential of this approach, it will be necessary both to understand the mechanism of ribozyme action in vitro and to optimize the in vivo activity of these molecules. Naturally occurring ribozymes are being identified with increasing frequency. First identified in the protozoan Tetrahymena thermophila, they have now been found in plant viroid and virusoid RNAs (3, 10, 21) , bacteria (32) , transcripts of satellite DNA-2 of the newt (9) , and an animal virus, hepatitis delta virus (31) . As the numbers increase, so does the observed diversity of the ribozymes, leading to their classification into several types based on cleavage chemistry, site specificity, and proposed secondary structure. For all naturally occurring ribozymes except RNase P (13) , the catalytic motif and the cleavage site lie on the same molecule; cleavage is thus assumed to be an intramolecular event. Recent studies, focusing mainly on the hammerhead class of ribozyme, have shown that ribozyme cleavage can occur in trans, as an intermolecular event, and that the catalytic core of a ribozyme can, by the addition of selected flanking sequences, be directed toward many sites on most RNA molecules (14) . Consequently, hammerhead ribozymes have been used in attempts to control gene expression in cell culture.
In mammalian cells, the approach has shown some promise. Ribozymes expressed by using a tRNA promoter (7) or a standard (polymerase II) promoter (4), or directly microinjected into the cell (28) , all led to marked diminution in target gene expression. Furthermore, an anti-human immunodeficiency virus type 1 (anti-gag) ribozyme stably expressed in a cell line was shown (by using polymerase chain reaction) to cleave target RNA at the appropriate site and to have diminished levels of RNA and protein (27) . However, many questions need to be addressed if ribozymes are to become valuable tools for the regulation of gene expression in general and antiviral agents in particular. How can ribozymes best be introduced into target cells? How can their intracellular stability be maximized? How can their ability to cycle be maximized? The rate-limiting step in ribozyme activity appears to be something other than the cleavage step (19) ; most probably, the limiting factor is in separation of ribozyme from its cleavage products, as reflected by the increase in ribozyme activity with decreasing lengths of flanking sequences (11, 33 viral proteins, these proteins might serve to distort the RNA structure thereby altering its availability or sensitivity to ribozymes. Therefore, we expressed Ribl to high levels (easily detected by Northern blot in samples of total cytoplasmic RNA) in tissue culture cells. However, we see little or no effect of Ribl expression on LCMV RNA levels (again judged by Northern blot; data not shown). We have not at present determined whether the in vivo resistance is due solely to target site secondary structure, but it is a possible contributory factor.
As well as demonstrating the effect of secondary structure on cis-acting ribozyme cleavage, we have shown trans activity of five ribozymes, all directed toward different target sites. We show that the trans activity of Ribl is, like its cis action, abolished by the presence of the stem-loop in the target RNA. However, we also find that there are substantial differences in the efficiencies of cleavage by these five ribozymes against target sites devoid of predicted secondary structure. This may reflect, for example, unknown higherorder target structure or the effects of the different sequences flanking the five cleavage sites; a similar phenomenon was noted by others (22) .
Although three of the four sites selected by analysis of computer predictions of LCMV S-segment secondary structure were efficiently cleaved in trans, the actual benefit derived from use of the computer program is uncertain. The program predicted the intergenic hairpin structure, which we have shown renders a target site resistant to ribozyme attack; it is possible that some or all of the other secondary structural motifs would have been similarly refractory to cleavage. However, in the absence of experimental data about the secondary structure of LCMV RNAs, it remains entirely possible that some of the predicted secondary structures are in fact absent; conversely, some of the regions that we have chosen may in reality be involved in base pairing. The value of such predictive schemes will be determined only when larger numbers of ribozyme-resistant and ribozyme-sensitive sites can be found and compared with those predicted by computer analysis.
The third criterion for target site selection is the presence of sequences at which ribozyme cleavage can occur. If, as argued above, potential target sites are restricted by considerations of mutability and accessibility, it becomes clear that only a few regions of the viral genome may be worthwhile targets; this diminution in potential target size carries with it the real possibility that no GUC cleavage site will be present. Indeed, in our studies, using only the criterion of target site secondary structure, many areas of the LCMV S and S' segments were excluded, and the regions which remained contained no GUC sites. Therefore, it becomes increasingly important to maximize the number of possible ribozyme cleavage sites within the areas selected by the first two criteria. To date, most published hammerhead ribozyme cleavage sites have been GUC. Here we show that GUC, AUC, CUC, and AUU all are cleaved by trans-acting hammerhead ribozymes, consistent with the report that NUX is an effective cut site (16) . NUX will occur with a random frequency 12-fold greater than that of GUC; as we now show, this can be critical given the possible restrictions imposed by the first two selection criteria.
We are encouraged to find that Rib3, Rib4 
